26 May 2013
Keywords: roche, cera, corrects, anemia, mm, patients, swiss
Article | 22 December 2003
Swiss drug major Roche's CERA (Continuous Erythropoiesis ReceptorActivator) showed promise in the correction of anemia in multiple
myeloma cancer patients, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 December 2003
15 December 2003
24 May 2013
© 2013 thepharmaletter.com